Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions
Contribution to Book
Advanced Pharmacology for Prescribers
Brent Luu, Gerald Kayingo, Virginia McCoy Hass
Musculoskeletal (MSK) and rheumatologic disorders were second only to maintenance healthcare needs as the primary reason for ambulatory care visits in the United States in 2015. The diagnosis of the majority of MSK and rheumatologic disorders is usually apparent, permitting empirical therapy. These disorders affect all ages, sexes, and races so patient characteristics and comorbidities should also be considered when choosing treatments. This chapter provides an overview of musculoskeletal and rheumatologic conditions, including epidemiological impact. It discusses the pathophysiology of musculoskeletal and rheumatologic disease states. The chapter presents an overview of medications used to treat musculoskeletal and rheumatologic conditions. It compares and contrasts the pharmacotherapy for these conditions to provide an understanding of the benefits and limitations of each drug. The chapter presents guidelines to select the most appropriate pharmacotherapeutic regimen to treat patients with musculoskeletal and rheumatologic conditions who may or may not have preexisting comorbidities and contraindications.
Find in WorldCat
Springer Publishing Company
New York, NY, USA
Medicine and Health Sciences
Sunseri, Rahnea and Barr, Erica, "Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions" (2021). Physician Assistant Faculty & Staff Books and Book Chapters. 4.